Download Endocrinology Test List

For Endocrinologists
Endocrinology Test List
Endocrinology Test List
Extensive Capabilities
Managing patients with endocrine disorders is complex. Having access to the
right test for the right patient is key. With a legacy of expertise in endocrine
laboratory diagnostics, Quest Diagnostics offers an extensive menu of
laboratory tests across the spectrum of endocrine disorders.
This test list highlights the extensive menu of laboratory diagnostic tests
we offer, including highly specialized tests and those performed using
highly specific and sensitive mass spectrometry detection. It is conveniently
organized by glandular function or common endocrine disorder, making it easy
for you to identify the tests you need to care for the patients you treat.
Comprehensive Care
Quest Diagnostics Nichols Institute has been
pioneering state-of-the-art endocrine testing
for over four decades. Our commitment to
innovative diagnostics and our dedication
to quality and service means we deliver
solutions that enable you to make informed
clinical decisions for comprehensive patient
management. We strive to remain at the
forefront of innovation in endocrine testing so
you can deliver the highest level of patient care.
Abbreviations and Footnotes
NDM, neonatal diabetes mellitus; MODY, maturity-onset diabetes of the young; CH, congenital hyperinsulinism; MSUD, maple syrup urine
disease; IHH, idiopathic hypogonadotropic hypogonadism; BBS, Bardet-Biedl syndrome; OI, osteogenesis imperfecta; PKD, polycystic kidney
disease; OPPG, osteoporosis-pseudoglioma syndrome; CPHD, combined pituitary hormone deficiency; GHD, growth hormone deficiency.
The tests highlighted in green are performed using highly specific and sensitive mass spectrometry detection. Panels that include a test(s)
performed using mass spectrometry are highlighted in yellow. For tests highlighted in blue, refer to the Athena Diagnostics website
(athenadiagnostics.com/content/test-catalog) for test information. These tests are performed by Athena Diagnostics.
†
ultiple test codes are available. Refer to the Quest Diagnostics Nichols Institute Directory of Services or the online Test Center
M
(QuestDiagnostics.com) for test information.
1
his test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute. Performance
T
characteristics refer to the analytical performance of the test.
2
his test was developed and its performance characteristics have been determined by Athena Diagnostics. Performance characteristics refer
T
to the analytical performance of the test.
3
his test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute. It has not been
T
cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
Performance characteristics refer to the analytical performance of the test.
4
his test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this
T
test have been determined by Quest Diagnostics Nichols Institute. This test should not be used for diagnosis without confirmation by other
medically established means.
Reflex tests are performed at an additional charge.
The following tests that are included in panels may be ordered separately: albumin, alkaline phosphatase, ALT, AST, bilirubin (direct and total),
creatinine (serum and urine), electrolyte panel, hemoglobin, hepatic function panel, iron, phosphate, potassium, and total protein.
Quest Diagnostics – Endocrinology Test List
Test Code
Test Name
Adrenal Medullary Function/Catecholamines
39627(X)
Catecholamines, Fractionated, 24-Hour Urine
314(X)
Catecholamines, Fractionated, Plasma
5244
Catecholamines, Fractionated, Random Urine
16381
Catecholamines, Fractionated, Supine, Plasma
16382
Catecholamines, Fractionated, Upright, Plasma
39626(X)
Catecholamines, Fractionated, and VMA, 24-Hour Urine
16379
Chromogranin A, Electrochemiluminescence1
39527(X)
Homovanillic Acid, 24-Hour Urine
6346
Homovanillic Acid, Random Urine
19548
Metanephrines, Fractionated, Free, LC/MS/MS, Plasma
14962(X)
Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine
14961(X)
Metanephrines, Fractionated, LC/MS/MS, Random Urine
889
Pheochromocytoma Evaluation2
39517(X)
VMA (Vanillylmandelic Acid), 24-Hour Urine
1710
VMA (Vanillylmandelic Acid), Random Urine
Detects mutations in RET, SDHB, and VHL.
Adrenocortical Function See below for congenital adrenal hyperplasia.
815
ABCD1 (Adrenoleukodystrophy) DNA Sequencing Test2
211
ACTH, Plasma
4645
Adrenal Antibody Screen with Reflex to Titer
19552(X)
229
Aldosterone, 24-Hour Urine
17181
Aldosterone, LC/MS/MS
†
Aldosterone/Cortisol Ratio
†
Aldosterone/Cortisol Ratio, Adrenal Vein Sampling
16845
Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS
5276(X)
3α-Androstanediol Glucuronide (3-Alpha Diol G)
17182
Androstenedione, LC/MS/MS
6547(X)
Corticosterone, LC/MS/MS
37371
Cortisol Binding Globulin (Transcortin)
37355(X)
Cortisol, Free and Cortisone, 24-Hour Urine
37077(X)
Cortisol, Free and Total, LC/MS/MS
36423(X)
Cortisol, Free, LC/MS/MS
11280(X)
Cortisol, Free, LC/MS/MS, 24-Hour Urine
90582
Cortisol, Free, LC/MS/MS, Second Void Urine
Congenital Adrenal Hyperplasia (CAH)
8181
Hemoglobin A1c with Calculated Mean Plasma Glucose
(MPG)
14755(X)
CAH (21-Hydroxylase Deficiency) Common Mutations1
Detects 11 CYP21A2 gene mutations and the 30kb deletion.
16802
Hemoglobin A1c with eAG
16072(X)
CAH (21-Hydroxylase Deficiency) Rare Mutations1
16715
Hemoglobin A1c with Reflex to GlycoMark®
802
HNF4A (MODY1) DNA Sequencing and Deletion Test2
37054(Z)
β-Hydroxybutyrate
36177(X)
IA-2 Antibody
36590
IGF Binding Protein-1 (IGFBP-1)1
853
INS (NDM) DNA Sequencing Test2
561
Insulin
36178
Insulin Autoantibody
36700
Insulin, Free (Bioactive)
91083
Insulin, LC/MS/MS
Includes androstenedione, cortisol, 11-deoxycortisol, DHEA,
17-hydroxypregnenolone, 17-hydroxyprogesterone, progesterone, and
total testosterone.
834
IPF1 (MODY4) DNA Sequencing Test2
841
IPF1 (NDM) DNA Sequencing Test2
CAH Panel 7 (steroid replacement therapy monitoring)
36741
Islet Cell Antibody Screen with Reflex to Titer2
843
KCNJ11 (NDM) DNA Sequencing Test2
15269(X)
15273(X)
15274(X)
15276(X)
Includes sequencing of the entire CYP21A2 gene.
CAH Panel 1 (21-OH vs 11-βOH)
Includes 17-hydroxyprogesterone/11-deoxycortisol ratio,
11-deoxycortisol/cortisol ratio, androstenedione, and total testosterone.
CAH Panel 3 (aldosterone synthase deficiency)
Includes 17-OH progesterone/11-deoxycortisol ratio, and
18-hydroxycorticosterone/aldosterone ratio.
CAH Panel 4 (17-OH deficiency in females)
Includes progesterone/17-hydroxyprogesterone ratio, corticosterone,
cortisol, aldosterone, and estradiol.
CAH Panel 6 (StAR deficiency)
Includes cortisol, pregnenolone, DHEA, and aldosterone.
CAH Panel 6C (Full Screen)
16978
15277(X)
15279(X)
15280(X)
Includes androstenedione, total testosterone, 17-hydroxyprogesterone.
CAH Panel 8 (17-OH deficiency in males)
91398
CAH Panel 9 (3β-HSD deficiency)
15281
Microalbumin, 24-Hour Urine (with Creatinine)
4555
Microalbumin, 24-Hour Urine (without Creatinine)
6517
Microalbumin, Random Urine (with Creatinine)
17674
Microalbumin, Random Urine (without Creatinine)
Includes 17-hydroxypregnenolone/17-hydroxyprogesterone ratio,
DHEA/androstenedione ratio, and cortisol.
CAH Panel 11, Neonatal Random Urine
10046(X)
Includes 17-OH pregnanolone; 15, 17-(OH)2-pregnanolone; 16-OH
DHEA; pregnanetriol; tetrahydro 11-deoxycortisol; pregnanetriolone; 16OH pregnenolone; pregnenetriol; tetrahydrocortisone; 6-OH tetrahydro
11-deoxycortisol; tetrahydro 11-dehydrocorticosterone; A-cortolone;
B-cortolone; and 6-OH tetrahydro 11-dehydrocorticosterone.
Congenital Adrenal Hyperplasia (CAH) Evaluation
2
879
Includes sequencing and deletion detection in CYP21A2 and
sequencing of CYP11B1.
875
CYP11B1 (CAH) DNA Sequencing Test
877
CYP17A1 DNA Sequencing Test2
2
CYP21A2 (CAH) DNA Evaluation
2
880
Metabolic Syndrome and Glucose Control Including Insulin
Includes progesterone/17-hydroxyprogesterone ratio, corticosterone,
cortisol, aldosterone, and total testosterone.
Includes sequencing of the entire CYP21A2 gene, as well as detection of
the common 30kb deletion.
30543
11-Deoxycortisol, LC/MS/MS, Serum
878
HSD3B2 DNA Sequencing Test2
17180
17-Hydroxyprogesterone, LC/MS/MS
17654(X)
17-Hydroxyprogesterone, Neonatal/Infant
885
Includes cholesterol, total and HDL; glucose; insulin, LC/MS/MS;
triglycerides; and calculated components.
Monogenic Diabetes (MODY) Evaluation2
Includes sequencing and deletion detection in GCK, HNF4A, TCF1,
and TCF2 and sequencing of IPF1.
882
Neonatal Diabetes Mellitus Evaluation2
678
Osmolality, Random Urine
677
Osmolality, Serum
760(X)
Proinsulin4
34480
Somatostatin1
804
TCF1 (MODY3) DNA Sequencing and Deletion Test2
805
TCF2 (MODY5) DNA Sequencing and Deletion Test2
Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11.
Dynamic Testing
17832(X)
Aldosterone, Response to ACTH Stimulation, LC/MS/MS
19511(X)
Detects mutations (including point mutations, deletions, insertions, and
rearrangements) in StAR.
Androstenedione Response to ACTH Stimulation,
LC/MS/MS
10068(X)
Catecholamines, Total, Suppression by Clonidine, Plasma
738
Pregnanetriol, Urine
16434
Cortisol, Free, Response to ACTH Stimulation
90397
Steroid Panel, 21-Hydroxylase Deficiency/
Stress Differentiation
38149(X)
Cortisol Response to ACTH Stimulation, Serum
Includes 17-hydroxyprogesterone, androstenedione, and cortisol.
†
C-Peptide Response to Glucose
Steroid Panel, Comprehensive
14747(X)
C-Peptide Stimulation by Glucagon
†
Growth Hormone, Multiple Specimens
17682(X)
17-Hydroxyprogesterone Response to ACTH Stimulation
†
Insulin Response to Glucose
Includes androstenedione, cortisol, deoxycorticosterone,
11-deoxycortisol, DHEA, 17-hydroxypregnenolone,
17-hydroxyprogesterone, progesterone, and total testosterone.
†
Proinsulin Response to Glucose4
Steroid Panel, PCOS/CAH Differentiation
4645
Adrenal Antibody with Reflex to Titer
812
Detects point mutations, deletions, insertions, and rearrangements
in AIRE.
Lipoid CAH (StAR) Evaluation
2
19897(X)
Cortisol, LC/MS/MS, Saliva
11281(X)
Cortisol, Total, LC/MS/MS
37554(X)
Cortisone, 24-Hour Urine
37098(X)
Cortisone, Serum3
90973
Deoxycorticosterone
30543
11-Deoxycortisol, LC/MS/MS, Serum
29391(X)
Dexamethasone
19894
DHEA (Dehydroepiandrosterone), Unconjugated,
LC/MS/MS
38954
DHEA (Dehydroepiandrosterone), Urine
402
DHEA Sulfate
36168
Dihydrotestosterone, Free, Serum1
90567
Dihydrotestosterone, LC/MS/MS1
36707(X)
Hirsutism Panel 2
Includes androstenedione, DHEA sulfate, and free and total testosterone.
Diabetes Mellitus, Types 1 and 2
15202
17-Hydroxycorticosteroids with Creatinine, 24-Hour Urine
876
ABCC8 (NDM) DNA Sequencing Test2
15114
Gastric Parietal Cell Antibody, ELISA
11178(X)
18-Hydroxycortisol, Free, 24-Hour Urine
15060(X)
Adiponectin4
34878
Glutamic Acid Decarboxylase-65 Antibody
38071(X)
6 Beta-Hydroxycortisol, 24-Hour Urine
837
CEL (MODY8) Mutation Analysis2
37072(X)
Growth Hormone Antibody3
21-Hydroxylase Antibody
874
90392
Includes androstenedione, corticosterone, cortisol, cortisone,
deoxycorticosterone, 11-deoxycortisol, DHEA, 18-hydroxycorticosterone,
17-hydroxypregnenolone, 17-hydroxyprogesterone, pregnenolone,
progesterone, and total testosterone.
Steroid Panel, Congenital Adrenal Hyperplasia (CAH)
90398
90426
Includes androstenedione, 11-deoxycortisol, DHEA,
17-hydroxyprogesterone, and free and total testosterone.
Endocrine Autoimmunity
Autoimmune Polyglandular Syndrome (AIRE) Evaluation2
37916(X)
21-Hydroxylase Antibody
372
C-Peptide
37916(X)
8352
17-Hydroxypregnenolone, LC/MS/MS
4643(X)
C-Peptide, 24-Hour Urine
36177(X)
IA-2 Antibody
17180
17-Hydroxyprogesterone, LC/MS/MS
36178
Insulin Autoantibody
17654(X)
17-Hydroxyprogesterone, Neonatal/Infant
Diabetes, Advancing Chronic Kidney Disease
Management Panel
36741
Islet Cell Antibody Screen with Reflex to Titer3
36578
PTH Antibody1
36574
T3 (Triiodothyronine) Antibody1
36576
T4 (Thyroxine) Antibody1
5738
TBII (Thyrotropin-Binding Inhibitory Immunoglobulin)
267
Thyroglobulin Antibody
Includes lipid panel (cholesterol, HDL, cholesterol/HDL ratio,
LDL-calculated, and triglycerides) with reflex to direct LDL, glucose,
and hemoglobin A1c.
7260(X)
Thyroid Peroxidase and Thyroglobulin Antibodies
5081
Thyroid Peroxidase Antibody (Anti-TPO)
15201(X)
17-Ketosteroids with Creatinine, 24-Hour Urine
70184(X)
17-Ketosteroids, Fractionated, Pediatrics, Urine
Includes electrolyte panel; microalbumin, random urine with creatinine;
creatinine, serum; hemoglobin; PTH, intact and calcium; phosphate
(as phosphorus); QuestAssureD™ 25-hydroxyvitamin D (D2, D3),
LC/MS/MS.
4932(X)
17-Ketosteroids, Fractionated, Urine
Diabetes, Newly Diagnosed and Monitoring Panel
814
NR0B1 (Adrenal Hypoplasia Congenita)
DNA Sequencing Test2
16846
Plasma Renin Activity, LC/MS/MS
738
Pregnanetriol, Urine
31493(X)
Pregnenolone, LC/MS/MS
8340
Fructosamine
36577
TSH Antibody1
Primary Adrenal Insufficiency Evaluation2
10584(X)
GAD65, IA-2, and Insulin Autoantibody
30551
TSI (Thyroid Stimulating Immunoglobulin)
803
GCK (MODY2) DNA Sequencing and Deletion Test2
Endocrine Genetics
816
Detects mutations (including point mutations, deletions, insertions, and
rearrangements) in ABCD1, AIRE, and NR0B1.
91713(X)
91712(X)
Includes glucose; hemoglobin A1c; lipid panel; hepatic function panel;
microalbumin, random urine with creatinine; creatinine, serum.
Diabetes Risk Assessment Panel
91920
17183
Progesterone, LC/MS/MS
842
GCK (NDM) DNA Sequencing Test2
827
ABCC8 (CH) DNA Sequence Test2
30740
Sex Hormone Binding Globulin
519
Glucagon1
815
ABCD1 (Adrenoleukodystrophy) DNA Sequencing Test2
14966
Testosterone, Free, Bioavailable, and Total, LC/MS/MS
†
Glucose
711
ACTN4 DNA Sequencing Test2
36170
Testosterone, Free (Dialysis) and Total (LC/MS/MS)
34878
Glutamic Acid Decarboxylase-65 Antibody
14531
Acylcarnitine, Plasma
37073
Testosterone, Total and Free and Sex Hormone
Binding Globulin
5032(X)
Glycated Albumin
29881
Amino Acid Analysis, LC/MS, CSF
15983
Testosterone, Total, LC/MS/MS
29488(X)
Glycohemoglobin, Total
767(X)
Amino Acid Analysis, LC/MS, Plasma
39613(X)
Tetrahydroaldosterone, Urine
19599
GlycoMark®
36183
Amino Acid Analysis, LC/MS, Urine
496
Hemoglobin A1c
19779(X)
Amino Acid Analysis for MSUD, LC/MS, Plasma
Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS)
Athena Diagnostics test
Panel includes LC/MS/MS test(s)
462
Anosmic Kallmann/IHH Evaluation2
Detects mutations in FGF8, FGFR1, GnRHR, KAL1, KISS1R, PROK2, and
PROKR2.
893
ApoB Mutation Analysis2
852
AQP2 (Nephrogenic Diabetes Insipidus) DNA
Sequencing Test2
812
887
Autoimmune Polyglandular Syndrome (AIRE) Evaluation2
Detects point mutations, deletions, insertions, and rearrangements
in AIRE.
Bardet-Biedl Syndrome Evaluation2
Detects mutations in BBS1, BBS2, and BBS10.
871
BBS1 (BBS) DNA Sequencing Test2
872
BBS2 (BBS) DNA Sequencing Test
886
BBS10 (BBS) DNA Sequencing Test2
14755(X)
CAH (21-Hydroxylase Deficiency) Common Mutations
16072(X)
CAH (21-Hydroxylase Deficiency) Rare Mutations
2
279
848
GnRHR DNA Sequencing Test2
16313
Growth Hormone Deficiency Evaluation2
Endocrine Hypertension
Includes sequencing and deletion detection in SHOX and sequencing
of GH1 and GHRHR.
XSense®, Fragile X with Reflex1
17181
Aldosterone, LC/MS/MS
775
HSD11B2 DNA Sequencing Test2
16845
Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS
895
Hypercholesterolemia Evaluation2
36718
Angiotensin II
Catecholamines, Fractionated, 24-Hour Urine
857
Hypophosphatemic Rickets Evaluation2
39627(X)
Detects mutations in FGF23 and PHEX2.
11281(X)
Cortisol, Total, LC/MS/MS
716
INF2 (FSGS) DNA Sequencing Test2
774
CYP11B1 DNA Sequencing Test2
CYP11B1/2 DNA Chimeric Gene Fusion Test2
717
Inherited Focal and Segmental Glomerulosclerosis (FSGS)
Evaluation2
779
881
Endocrine Hypertension (HSD11B2) Evaluation2
775
HSD11B2 DNA Sequencing Test2
11178(X)
18-Hydroxycortisol, Free, 24-Hour Urine
Detects mutations in LDLR and disease-associated regions of ApoB.
Detects mutations in ACTN4, INF2, NPHS2, and TRPC6.
173
KAL1 DNA Sequencing Test2
826
KCNJ11 (CH) DNA Sequencing Test
364
KISS1R DNA Sequencing Test2
747
Liddle's Syndrome Evaluation2
Includes sequencing of the entire CYP21A2 gene.
664
KRAS DNA Sequencing Test2
14962(X)
Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine
90649
Cardio IQ™ ApoE Genotype1
658
KRAS/RAF1/SOS1 DNA Sequencing Evaluation2
Monogenic Hypertension Evaluation2
70107(X)
Carnitine, LC/MS/MS
714
LAMB2 DNA Sequencing Test2
749
15948(X)
Carnitine, LC/MS/MS and Acylcarnitine
894
LDLR (Hypercholesterolemia) DNA Sequencing Test2
825
CASR DNA Sequencing Test
747
Liddle's Syndrome Evaluation
461
CHD7 DNA Sequencing Test2
16478
Chromosomal Microarray, Postnatal,
ClariSure® Oligo-SNP1
821
LRP5 Idiopathic Osteoporosis (IOP)
DNA Sequencing Test2
811
LRP5 (OPPG) DNA Sequencing Test
17625(X)
Male Infertility Genetic Analysis
817
Male Precocious Puberty (LHCGR) DNA Sequencing Test
818
MEN1 (MEN1) DNA Sequencing Test2
813
MEN2 (RET) DNA Sequencing Test2
91002
Methylmalonic Acid, GC/MS/MS
91032
Methylmalonic Acid, GC/MS/MS, Urine
749
Monogenic Hypertension Evaluation
1
Detects 11 CYP21A2 gene mutations and the 30kb deletion.
1
2
14596(X)
Chromosome Analysis, Blood
14595(X)
Chromosome Analysis, High Resolution
14597(X)
Chromosome Analysis, Mosaicism
16843
Chromosome Analysis, Neonatal Blood
14593(X)
Chromosome Analysis, Tissue
861
COL1A1 (OI) DNA Sequencing Test2
862
COL1A2 (OI) DNA Sequencing Test2
865
Combined Pituitary Hormone Deficiency Evaluation2
2
Detects mutations in SCNN1B and SCNN1G.
Detects mutations in CYP11B1, HSD11B2, SCNN1B, and SCNN1G.
Pheochromocytoma Evaluation
10520
2
Detects mutations in SCNN1B and SCNN1G.
2
2
Includes total catecholamines, catecholamine/creatinine ratio, total
metanephrines, metanephrine/creatinine ratio, and creatinine (24-hour
urine).
748
Pseudohypoaldosteronism Type 1 Evaluation2
772
SCNN1A DNA Sequencing Test2
745
SCNN1B DNA Sequencing Test2
Detects mutations in SCNN1A, SCNN1B, and SCNN1G.
Fluid, Electrolytes, and Renal Function
711
ACTN4 DNA Sequencing Test
19552(X)
229
Aldosterone, 24-Hour Urine
17181
Aldosterone, LC/MS/MS
†
Aldosterone/Cortisol Ratio
Detects mutations in CYP11B1, HSD11B2, SCNN1B, and SCNN1G.
†
Aldosterone/Cortisol Ratio, Adrenal Vein Sampling
851
Nephrogenic Diabetes Insipidus (AVPR2)
DNA Sequencing Test2
16845
Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS
36718
Angiotensin II
854
Nephrogenic Diabetes Insipidus Evaluation2
Includes DNA sequencing of AQP2 and AVPR2.
852
AQP2 (Nephrogenic Diabetes Insipidus)
DNA Sequencing Test2
721
Nephrotic Syndrome Evaluation
252(X)
Arginine Vasopressin (AVP, Antidiuretic Hormone, ADH)3
882
Neonatal Diabetes Mellitus Evaluation
761
Complete PKD Evaluation2
647
6547(X)
Corticosterone, LC/MS/MS
Includes sequencing of the entire CYP21A2 gene, as well as detection of
the common 30kb deletion.
Neurofibromatosis Type 1 Deletion Test2
Detects deletions in NF1.
37371
Cortisol Binding Globulin (Transcortin)
10917(X)
Cystic Fibrosis Complete Rare Mutation Analysis, Entire Gene
Sequence1
646
Neurofibromatosis Type 1 DNA Sequencing Test2
36423(X)
Cortisol, Free, LC/MS/MS
Cortisol, Free, LC/MS/MS, 24-Hour Urine
16080(X)
Cystic Fibrosis Gene Deletion or Duplication3
648
Neurofibromatosis Type 1 (NF1) Evaluation2
11280(X)
Detects deletions and mutations in NF1.
90582
Cortisol, Free, LC/MS/MS, Second Void Urine
10913(X)
Cystic Fibrosis Rare Mutation Analysis, One Exon3
846
Noonan Syndrome (PTPN11) DNA Sequencing Test2
37355(X)
Cortisol, Free and Cortisone, 24-Hour Urine
10915(X)
Cystic Fibrosis Rare Mutation Analysis, Two Exon3
Normosmic Kallmann/IHH Evaluation2
37077(X)
Cortisol, Free and Total, LC/MS/MS
10458(X)
Cystic Fibrosis Screen1
19897(X)
Cortisol, LC/MS/MS, Saliva
10947(X)
Detects mutations in POU1F1 and PROP1.
Complete Kallmann/IHH Evaluation
2
679
Detects mutations in CHD7, FGF8, FGFR1, GnRHR, GnRH1, KAL1, KISS1R,
PROK2, PROKR2, and TACR3.
761
Complete PKD Evaluation2
774
CYP11B1 DNA Sequencing Test2
779
CYP11B1/2 DNA Chimeric Gene Fusion Test2
880
Detects mutations and deletions in PKD1 and PKD2.
CYP21A2 (CAH) DNA Evaluation2
2
2
Detects sequence variations in LAMB2, NPHS1, NPHS2, and WT1.
2
Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11.
Detects mutations in NF1.
Detects mutations and deletions in PKD1 and PKD2.
667
Detects mutations in FGFR1, GnRH1, GnRHR, KISS1R, PROK2, PROKR2,
and TACR3.
Cystine, 24-Hour Urine
710
NPHS2 (Podocin) Sequencing Analysis2
11281(X)
Cortisol, Total, LC/MS/MS
401(X)
Cystine, Quantitative, Random Urine
90404
Organic Acids, Qualitative, Urine
37554(X)
Cortisone, 24-Hour Urine
884
Early Onset Obesity Evaluation2
90561
Organic Acids, Full Panel, Quantitative, Urine
37098(X)
Cortisone, Serum3
883
Early Onset Obesity (LEPR) DNA Sequencing Test
860
Osteogenesis Imperfecta Evaluation2
10570(X)
Cystatin C
37356
Phenylalanine
Deoxycorticosterone, LC/MS/MS
640
Early Onset Obesity (MC4R) DNA Sequencing Test2
90973
Endocrine Hypertension (HSD11B2) Evaluation
Phenylalanine and Tyrosine
18-Hydroxycortisol, Free, 24-Hour Urine
881
26336(X)
11178(X)
INF2 (FSGS) DNA Sequencing Test2
889
Pheochromocytoma Evaluation2
716
Detects mutations in VHL, RET and SDHB.
718
PLCE1 DNA Sequencing Test
715
Inherited Focal and Segmental Glomerulosclerosis
(FSGS) Evaluation2
864
POU1F1 (CPHD) DNA Sequencing Test2
863
PROP1 (CPHD) DNA Sequencing Test2
717
Inherited Focal and Segmental Glomerulosclerosis
(FSGS) Evaluation2
855
PHEX (Hypophosphatemic Rickets)
DNA Sequencing Test2
829
Detects mutations in LEPR and MC4R.
2
Detects mutations in MC4R.
Familial Hypocalciuric Hypercalcemia (CASR)
DNA Sequencing Test
195
FGF8 DNA Sequencing Test2
856
FGF23 (Hypophosphatemic Rickets)
DNA Sequencing Test2
196
FGFR1 DNA Sequencing Test2
14608(X)
FISH, Angelman3
37343(X)
FISH, Chromosome-Specific Probe (specify probe &
chromosome number)3
14610(X)
FISH, DiGeorge, Velocardiofacial (VCFS)3
14615(X)
FISH, Kallmann3
36053
FISH, Neonatal Screen3
14605(X)
FISH, Prader Willi3
14606(X)
Detects mutations in COL1A1 and COL1A2.
2
Detects mutations in ACTN4, NPHS2, and TRPC6.
Detects mutations in ACTN4, INF2, NPHS2, and TRPC6.
714
LAMB2 DNA Sequencing Test2
15281
Microalbumin, 24-Hour Urine (with Creatinine)
11369
Prader-Willi/Angelman Syndrome,
DNA Methylation Analysis3
4555
Microalbumin, 24-Hour Urine (without Creatinine)
175
PROK2 DNA Sequencing Test2
6517
Microalbumin, Random Urine (with Creatinine)
180
PROKR2 DNA Sequencing Test2
17674
Microalbumin, Random Urine (without Creatinine)
748
Pseudohypoaldosteronism Type 1 Evaluation2
851
Nephrogenic Diabetes Insipidus (AVPR2)
DNA Sequencing Test2
663
RAF1 DNA Sequencing Test2
Nephrogenic Diabetes Insipidus Evaluation2
FISH, SRY/X Centromere
772
SCNN1A DNA Sequencing Test
854
14609(X)
FISH, Williams3
745
SCNN1B DNA Sequencing Test
721
Nephrotic Syndrome Evaluation2
14613(X)
FISH, Wolf-Hirschhorn3
888
SDHB DNA Sequencing Test2
710
NPHS2 (Podocin) Sequencing Analysis
14607(X)
FISH, X-Linked Ichthyosis Steroid Sulfatase Deficiency3
91566
SHOX (GHD) DNA Sequencing and Deletion Test3
678
Osmolality, Random Urine
823
GCK (CH) DNA Sequencing Test2
662
SOS1 DNA Sequencing Test2
677
Osmolality, Serum
866
GH1 (GHD) DNA Sequencing Test2
358
TACR3 DNA Sequencing Test2
16846
Plasma Renin Activity, LC/MS/MS
867
GHR DNA Sequencing Test2
712
TRPC6 DNA Sequencing Test2
718
PLCE1 DNA Sequencing Test2
868
GHRHR (GHD) DNA Sequencing Test2
959
Tryptophan, LC/MS
712
TRPC6 DNA Sequencing Test2
822
GLUD1 (CH) DNA Sequencing Test2
902
Tyrosine
713
WT1 DNA Sequencing Test2
90915
Glycogen Storage Disease Type 1a Mutation Analysis
(Ashkenazi Jewish)3
858
Von Hippel-Lindau Syndrome (VHL) Evaluation2
Gonadal Function
343
GnRH1 DNA Sequencing Test
713
WT1 DNA Sequencing Test2
8658(X)
3
2
Detects mutations in SCNN1A, SCNN1B, and SCNN1G.
2
2
Includes DNA sequencing of AQP2, and AVPR2.
Detects sequence variations in LAMB2, NPHS1, NPHS2, and WT1.
Alpha Subunit3
5276(X)
3α-Androstanediol Glucuronide (3-Alpha Diol G)
846
Noonan Syndrome (PTPN11) DNA Sequencing Test2
837
CEL (MODY8) Mutation Analysis2
17182
Androstenedione, LC/MS/MS
864
POU1F1 (CPHD) DNA Sequencing Test2
372
C-Peptide
Anosmic Kallmann/IHH Evaluation2
746
Prolactin
4643(X)
C-Peptide, 24-Hour Urine
863
PROP1 (CPHD) DNA Sequencing Test2
Anti-Müllerian Hormone AssessR™1
91566
SHOX (GHD) DNA Sequencing and Deletion
Complete Kallmann/IHH Evaluation2
662
SOS1 DNA Sequencing Test2
462
16842(X)
679
Detects mutations in FGF8, FGFR1, GnRHR, KAL1, KISS1R, PROK2,
and PROKR2.
Detects mutations in CHD7, FGF8, FGFR1, GnRHR, GnRH1, KAL1, KISS1R,
PROK2, PROKR2, and TACR3.
35167
T4, Free, Direct Dialysis
19894
DHEA (Dehydroepiandrosterone), Unconjugated,
LC/MS/MS
866
T4, Free (Non-dialysis)
17733
T4, Total (Thyroxine)
38954
DHEA (Dehydroepiandrosterone), Urine
Hypothalamic and Pituitary Function
402
DHEA Sulfate
211
ACTH, Plasma
90567
Dihydrotestosterone, LC/MS/MS1
8658(X)
Alpha Subunit
36168
Dihydrotestosterone, Free, Serum
252(X)
36169
Estradiol, Free, LC/MS/MS
30289
Estradiol, Ultrasensitive, LC/MS/MS
439
Estrogen, Total, Serum
36742
Estrogens, Fractionated, LC/MS/MS
23244
Estrone, LC/MS/MS
37104(X)
Estrone Sulfate
470
FSH (Follicle Stimulating Hormone)
36087
FSH (Follicle Stimulating Hormone), Pediatrics1
7137
FSH and LH
36176
FSH and LH, Pediatrics1
8396
hCG, Total, Quantitative
19720
hCG, Total, with HAMA Treatment
36707(X)
Hirsutism Panel 2
91713(X)
91712(X)
Diabetes, Advancing Chronic Kidney Disease
Management Panel
Includes electrolyte panel; microalbumin, random urine with creatinine;
creatinine, serum; hemoglobin; PTH, intact and calcium; phosphate (as
phosphorus); QuestAssureD™ 25-hydroxyvitamin D (D2, D3),
LC/MS/MS.
Diabetes, Newly Diagnosed and Monitoring Panel
Includes glucose; hemoglobin A1c; lipid panel; hepatic function panel;
microalbumin, random urine with creatinine; creatinine, serum.
884
Early Onset Obesity Evaluation2
883
Early Onset Obesity (LEPR) DNA Sequencing Test2
Arginine Vasopressin (AVP, Antidiuretic Hormone, ADH)
640
Detects mutations in MC4R.
865
Combined Pituitary Hormone Deficiency Evaluation2
90393
Fat Malabsorption (Response to Vitamin D2 Supplement)
470
FSH (Follicle Stimulating Hormone)
8340
Fructosamine
36087
FSH (Follicle Stimulating Hormone), Pediatrics
10584(X)
GAD65, IA-2, and Insulin Autoantibody
7137
FSH and LH
478(X)
Gastrin
36176
FSH and LH, Pediatrics
803
GCK (MODY2) DNA Sequencing and Deletion Test2
866
GH1 (GHD) DNA Sequencing Test2
842
GCK (NDM) DNA Sequencing Test2
521
Growth Hormone (GH)
519
Glucagon1
37072(X)
Growth Hormone Antibody3
†
Glucose
615
LH
34878
Glutamic Acid Decarboxylase-65 Antibody
36086
LH, Pediatrics1
5032(X)
Glycated Albumin
864
POU1F1 (CPHD) DNA Sequencing Test2
90915
746
Prolactin
Glycogen Storage Disease Type 1a Mutation Analysis
(Ashkenazi Jewish)1
Includes androstenedione, DHEA sulfate, and free and total testosterone.
40049
Prolactin, Dilution Study
29488(X)
Glycohemoglobin, Total
8352
17-Hydroxypregnenolone, LC/MS/MS
16122
Prolactin, Total and Monomeric
19599
GlycoMark®
17180
17-Hydroxyprogesterone, LC/MS/MS
863
PROP1 (CPHD) DNA Sequencing Test2
496
Hemoglobin A1c
17654(X)
17-Hydroxyprogesterone, Neonatal/Infant
34480
Somatostatin
8181
Hemoglobin A1c with Calculated Mean Plasma Glucose
(MPG)
11303
Hyperglycosylated hCG (h-hCG)
899
TSH
16802
Hemoglobin A1c with eAG
34472
Inhibin A
36577
TSH Antibody1
16715
Hemoglobin A1c with Reflex to GlycoMark®
34445
Inhibin B1
19537
TSH with HAMA Treatment
15201(X)
17-Ketosteroids with Creatinine, 24-Hour Urine
Lipid Disorders
39625(X)
5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine, with
Creatinine
70184(X)
17-Ketosteroids, Fractionated, Pediatrics, Urine
15060(X)
Adiponectin4
523(X)
4932(X)
17-Ketosteroids, Fractionated, Urine
893
ApoB Mutation Analysis2
5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine, without
Creatinine
615
LH
5223(X)
Apolipoprotein A1
1648(X)
5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine
36086
LH, Pediatrics1
5224(X)
Apolipoprotein B
802
HNF4A (MODY1) DNA Sequencing and Deletion Test2
17625(X)
Male Infertility Genetic Analysis
37054(Z)
β-Hydroxybutyrate
817
Male Precocious Puberty (LHCGR) DNA Sequencing Test2
36177(X)
IA-2 Antibody
36590
IGF Binding Protein-1 (IGFBP-1)1
1
Normosmic Kallmann/IHH Evaluation
2
667
Detects mutations in FGFR1, GnRH1, GnRHR, KISS1R, PROK2, PROKR2,
and TACR3.
7018(X)
1
3
Detects mutations in POU1F1 and PROP1.
1
1
1
Apolipoprotein Evaluation
Includes apolipoprotein A1, apolipoprotein B, and apolipoprotein
B/A1 ratio.
Detects mutations in LEPR and MC4R.
Early Onset Obesity (MC4R) DNA Sequencing Test2
887
Bardet-Biedl Syndrome Evaluation2
Detects mutations in BBS1, BBS2, and BBS10.
37102(X)
IGF Binding Protein-2 (IGFBP-2)1
886
BBS10 (BBS) DNA Sequencing Test
34458
IGF Binding Protein-3 (IGFBP-3)
90649
Cardio IQ™ ApoE Genotype1
16293
IGF-I, LC/MS1
91604
Cardio IQ™ Lipoprotein Fractionation, Ion Mobility
853
INS (NDM) DNA Sequencing Test2
334(X)
Cholesterol, Total
561
Insulin
8293(X)
Direct LDL
36178
Insulin Autoantibody
36700
Insulin, Free (Bioactive)
91083
Insulin, LC/MS/MS1
834
IPF1 (MODY4) DNA Sequencing Test2
841
IPF1 (NDM) DNA Sequencing Test2
36741
Islet Cell Antibody Screen with Reflex to Titer2
843
KCNJ11 (NDM) DNA Sequencing Test2
90367
Leptin3
91398
Includes cholesterol, total and HDL; glucose; insulin, LC/MS/MS;
triglycerides; and calculated components.
2
10328
Ovarian Antibody Screen with Reflex to Titer
31493(X)
Pregnenolone, LC/MS/MS
17183
Progesterone, LC/MS/MS
746
Prolactin
40049
Prolactin, Dilution Study
16122
Prolactin, Total and Monomeric
884
Early Onset Obesity Evaluation2
30740
Sex Hormone Binding Globulin
883
Early Onset Obesity (LEPR) DNA Sequencing Test2
640
Early Onset Obesity (MC4R) DNA Sequencing Test2
90393
Fat Malabsorption (Response to Vitamin D2 Supplement)
Includes androstenedione, DHEA, and total and free testosterone.
608(X)
HDL Cholesterol
Steroid Panel, Premature Adrenarche
35932(X)
HDL Cholesterol Subclasses
31789
Homocysteine (Cardiovascular)
895
Hypercholesterolemia Evaluation2
Detects mutations in LDLR and disease-associated regions of ApoB.
15281
Microalbumin, 24-Hour Urine (with Creatinine)
894
LDLR (Hypercholesterolemia) DNA Sequencing Test2
4555
Microalbumin, 24-Hour Urine (without Creatinine)
90367
Leptin1
6517
Microalbumin, Random Urine (with Creatinine)
Lipid Panel
17674
Microalbumin, Random Urine (without Creatinine)
885
Includes sequencing and deletion detection in GCK, HNF4A, TCF1, and
TCF2 and sequencing of IPF1.
90426
90424
90433
Steroid Panel, PCOS/CAH Differentiation
Includes androstenedione, 11-deoxycortisol, DHEA,
17-hydroxyprogesterone, and free and total testosterone.
Steroid Panel, Polycystic Ovary Syndrome (PCOS)
Includes androstenedione, DHEA, 17-hydroxypregnenolone,
17-hydroxyprogesterone, and total testosterone.
14966
Testosterone, Free, Bioavailable, and Total, LC/MS/MS
15983
Testosterone, Total, LC/MS/MS
19958
Testosterone, Total (Males), Immunoassay
37073
Testosterone, Total and Free and Sex Hormone
Binding Globulin
7600(X)
Growth and Growth Hormone
865
Combined Pituitary Hormone Deficiency Evaluation
866
GH1 (GHD) DNA Sequencing Test2
867
GHR DNA Sequencing Test2
868
GHRHR (GHD) DNA Sequencing Test2
521
37072(X)
848
2
Detects mutations in POU1F1 and PROP1.
14852(X)
Detects mutations in LEPR and MC4R.
Detects mutations in MC4R.
Includes HDL and total cholesterol, triglycerides, and calculated
components (LDL-cholesterol, cholesterol:HDL-cholesterol ratio, and
non-HDL cholesterol).
Lipid Panel w/Reflex to Direct LDL
Metabolic Syndrome and Glucose Control Including Insulin
Monogenic Diabetes (MODY) Evaluation2
Neonatal Diabetes Mellitus Evaluation2
Includes cholesterol, HDL, cholesterol/HDL ratio, LDL (calculated),
and triglycerides.
882
Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11.
34604(X)
Lipoprotein(a)
449(X)
Nonesterified Fatty Acids (Free Fatty Acids)
449(X)
Nonesterified Fatty Acids (Free Fatty Acids)
678
Osmolality, Random Urine
Growth Hormone (GH)
91001
Omega-3 and -6 Fatty Acids, Plasma
677
Osmolality, Serum
Growth Hormone Antibody3
717
Phospholipids4
4789(X)
Pancreatic Polypeptide3
Growth Hormone Deficiency Evaluation
896
Triglycerides
760(X)
Proinsulin4
90559
Very Long Chain Fatty Acids
17306
QuestAssureD™ 25-Hydroxyvitamin D (D2, D3),
LC/MS/MS
91935
QuestAssureD™ for Infants, 25-Hydroxyvitamin D,
LC/MS/MS
16761
QuestAssureD™ 25-Hydroxy and 1,25-Dihydroxyvitamin
D, LC/MS/MS
34480
Somatostatin1
818(X)
Serotonin, Blood
Includes sequencing and deletion detection in SHOX and sequencing
of GH1 and GHRHR.
†
Growth Hormone, Multiple Specimens
Metabolic (Including Diabetes Mellitus) and Gastrointestinal Disorders
16293
IGF-I, LC/MS1
876
ABCC8 (NDM) DNA Sequencing Test2
36590
IGF Binding Protein-1 (IGFBP-1)1
15060(X)
Adiponectin4
37102(X)
IGF Binding Protein-2 (IGFBP-2)1
887
Bardet-Biedl Syndrome Evaluation2
34458
IGF Binding Protein-3 (IGFBP-3)
658
KRAS/RAF1/SOS1 DNA Sequencing Evaluation2
886
BBS10 (BBS) DNA Sequencing Test2
825
CASR DNA Sequencing Test2
Detects mutations in BBS1, BBS2, and BBS10.
804
TCF1 (MODY3) DNA Sequencing and Deletion Test2
7573
Iron, Total and Total Iron binding Capacity
805
TCF2 (MODY5) DNA Sequencing and Deletion Test2
90367
Leptin1
920(X)
Vasoactive Intestinal Polypeptide (VIP)1
90559
Very Long Chain Fatty Acids
16558
Vitamin D, 1,25-Dihydroxy, LC/MS/MS
Multiple Endocrine Neoplasia
211
ACTH, Plasma
30742(X)
Calcitonin
303
Calcium
1635(X)
Calcium, 24-Hour Urine (with Creatinine)
306
Calcium, Ionized
11216(X)
Calcium, Pediatric Urine (with Creatinine)
1633(X)
Calcium, Random Urine (with Creatinine)
39627(X)
Catecholamines, Fractionated, 24-Hour Urine
314(X)
Catecholamines, Fractionated, Plasma
5244
Catecholamines, Fractionated, Random Urine
16381
Catecholamines, Fractionated, Supine, Plasma
16382
Catecholamines, Fractionated, Upright, Plasma
39626(X)
15102(X)
Lipid Panel
7600(X)
Includes HDL and total cholesterol, and triglycerides; calculated
components include LDL-cholesterol, chol/HDL ratio, and
non-HDL cholesterol.
34604(X)
Lipoprotein(a)
17306
QuestAssureD™ 25-Hydroxyvitamin D (D2, D3),
LC/MS/MS
90353
Vitamin B1 (Thiamine), LC/MS/MS
Parathyroid and Mineral Metabolism
29498
Alkaline Phosphatase, Bone Specific
231
Alkaline Phosphatase Isoenzymes
812
870
Autoimmune Polyglandular Syndrome (AIRE) Evaluation2
Detects point mutations, deletions, insertions, and rearrangements
in AIRE.
TBG (Thyroxine Binding Globulin)
Thyroid Cascading Reflex
Initial TSH results will determine further reflex orders of Free T4, TPO
antibodies, and Free T3.
899
TSH
36577
TSH Antibody1
90896
TSH, Pregnancy
19537
TSH with HAMA Treatment
36127(X)
TSH with Reflex to Free T4
30551
TSI (Thyroid Stimulating Immunoglobulin)
Selective Sampling-Petrosal Sinus and Adrenal Vein Sampling
211
ACTH, Plasma
18821
Aldosterone/Cortisol Ratio, 2 Sites
18822
Aldosterone/Cortisol Ratio, 3 Sites
18823
Aldosterone/Cortisol Ratio, 4 Sites
18825
Aldosterone/Cortisol Ratio, 5 Sites
18826
Aldosterone/Cortisol Ratio, 6 Sites
30742(X)
Calcitonin
36167(X)
Collagen Cross-Linked N-Telopeptide (NTx),
2-Hour Urine or Second AM Void
36421
Collagen Cross-Linked N-Telopeptide (NTx),
24-Hour Urine
18827
Aldosterone/Cortisol Ratio, 7 Sites
18824
Aldosterone/Cortisol Ratio, 8 Sites
Catecholamines, Fractionated, and VMA, 24-Hour Urine
17406
Collagen Type I C-Telopeptide (CTx)
19573(X)
Aldosterone/Cortisol Ratio, Adrenal Vein Sampling
16379
Chromogranin A, Electrochemiluminescence1
372
C-Peptide
829
Familial Hypocalciuric Hypercalcemia (CASR) DNA
Sequencing Test2
18818
Aldosterone/Cortisol Ratio, Adrenal Vein Sampling
3 Sites
4643(X)
C-Peptide, 24-Hour Urine
91001
Omega-3 and -6 Fatty Acids, Plasma
Gastrin
16322
Osteocalcin, N-MID
18819
478(X)
Aldosterone/Cortisol Ratio, Adrenal Vein Sampling
5 Sites
519
Glucagon1
16609
Procollagen Type I Intact N Terminal Propeptide
Thyroid Cancer
521
Growth Hormone (GH)
36578
PTH Antibody1
90477
BRAF Mutation Analysis, Papillary Thyroid Cancer1
39625(X)
5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine
36736
PTH, Intact (ICMA) and Ionized Calcium
30742(X)
Calcitonin
1648(X)
5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine
8837
PTH, Intact and Calcium
978(X)
Carcinoembryonic Antigen (CEA)
39527(X)
Homovanillic Acid, 24-Hour Urine
16560
PTH, Intact, Fine Needle Aspirate
15018
CEA with HAMA Treatment
6346
Homovanillic Acid, Random Urine
34478(X)
PTH-Related Protein (PTH-RP)4
90474
PAX8/PPAR[gamma] Translocation, Thyroid Cancer1
561
Insulin
17306
90479
RAS Mutation Analysis, Thyroid Cancer1
36700
Insulin, Free (Bioactive)
QuestAssureD™ 25-Hydroxyvitamin D (D2, D3),
LC/MS/MS
90473
RET/PTC Rearrangement, Thyroid Cancer1
91083
Insulin, LC/MS/MS
91935
QuestAssureD™ for Infants, 25-Hydroxyvitamin D,
LC/MS/MS
267
Thyroglobulin Antibody
36587(X)
MEN2 and FMTC Mutations, Exons 10, 11, 13-161
30278
Thyroglobulin Panel
14962(X)
Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine
16761
QuestAssureD™ 25-Hydroxy and 1,25-Dihydroxyvitamin D,
LC/MS/MS
19548
Metanephrines, Fractionated, Free, LC/MS/MS, Plasma
16558
Vitamin D, 1,25-Dihydroxy, LC/MS/MS
19584
14961(X)
Metanephrines, Fractionated, LC/MS/MS, Random Urine
4789(X)
Pancreatic Polypeptide3
1
Pituitary Tumors
211
ACTH, Plasma
889
Pheochromocytoma Evaluation2
8658(X)
Alpha Subunit
Detects mutations in RET, SDHB, and VHL.
252(X)
Arginine Vasopressin (AVP, Antidiuretic Hormone, ADH)3
760(X)
Proinsulin4
16379
Chromogranin A, Electrochemiluminescence1
746
Prolactin
37077(X)
Cortisol, Free and Total, LC/MS/MS
40049
Prolactin, Dilution Study
36423(X)
16122
Prolactin, Total and Monomeric
11280(X)
36736
PTH, Intact (ICMA) and Ionized Calcium
8837
16560
1
16559
Includes thyroglobulin and thyroglobulin antibody.
Thyroglobulin Panel with HAMA Treatment
Includes thyroglobulin, pre and post HAMA precipitation, and
thyroglobulin antibody.
Thyroglobulin, Fine Needle Aspirate
Thyroid Cancer Monitoring1
90814
Includes a thyroglobulin antibody test. If positive, reflexes to thyroglobulin
measurement using LC/MS/MS. If negative, reflexes to thyroglobulin
measurement using a highly sensitive immunoassay.
90469
Thyroid Cancer Mutation Panel
(BRAF, RAS, RET/PTC, PAX8/PPAR)1
Cortisol, Free, LC/MS/MS
90819
Thyroid FNA Cytomorphology Evaluation
Cortisol, Free, LC/MS/MS, 24-Hour Urine
90818
Thyroid FNA Cytomorphology with Molecular Reflex
90582
Cortisol, Free, LC/MS/MS, Second Void Urine
Thyroid Function See above for thyroid cancer.
PTH, Intact and Calcium
19897(X)
Cortisol, LC/MS/MS, Saliva
30742(X)
Calcitonin
PTH, Intact, Fine Needle Aspirate
11281(X)
Cortisol, Total, LC/MS/MS
16053(X)
Resistance to Thyroid Hormone (RTH) Mutation Analysis1
34478(X)
PTH-Related Protein (PTH-RP)1
470
FSH (Follicle Stimulating Hormone)
90963
T3, Reverse, LC/MS/MS
818(X)
Serotonin, Blood
36087
FSH (Follicle Stimulating Hormone), Pediatrics1
36574
T3 (Triiodothyronine) Antibody1
29851
Serotonin, Serum
T3, Free, Non-Dialysis
Vasoactive Intestinal Polypeptide (VIP)1
14570
34429
920(X)
FSH (Follicle Stimulating Hormone),
Timed (5 Samples), Pediatrics1
36598
T3, Free, Tracer Dialysis
39517(X)
VMA, 24-Hour Urine
7137
FSH and LH
859
T3, Total
1710
VMA (Vanillylmandelic Acid), Random Urine
36176
FSH and LH, Pediatrics1
17732(X)
T3, Uptake
Neuroendocrine Markers
521
Growth Hormone (GH)
36576
T4, (Thyroxine) Antibody1
16379
Chromogranin A, Electrochemiluminescence1
37072(X)
Growth Hormone Antibody3
35167
T4, Free, Direct Dialysis
39625(X)
5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine
34458
IGF Binding Protein-3 (IGFBP-3)
866
T4, Free (Non-dialysis)
1648(X)
5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine
16293
IGF-I, LC/MS1
17733
T4, Total (Thyroxine)
39527(X)
Homovanillic Acid, 24-Hour Urine
615
LH
870
TBG (Thyroxine Binding Globulin)
6346
Homovanillic Acid, Random Urine
36086
LH, Pediatrics1
5738
TBII (Thyrotropin-Binding Inhibitory Immunoglobulin)
39517(X)
VMA, 24-Hour Urine
746
Prolactin
267
Thyroglobulin Antibody
1710
VMA (Vanillylmandelic Acid), Random Urine
40049
Prolactin, Dilution Study
Thyroglobulin Panel
920(X)
Vasoactive Intestinal Polypeptide (VIP)1
16122
Prolactin, Total and Monomeric
30278
34480
Somatostatin1
34480
Somatostatin1
Obesity and Post-Obesity Surgery
899
TSH
15060(X)
Adiponectin4
36577
TSH Antibody1
887
Bardet-Biedl Syndrome Evaluation2
19537
TSH with HAMA Treatment
886
BBS10 (BBS) DNA Sequencing Test2
90649
Cardio IQ™ ApoE Genotype1
91604
Cardio IQ™ Lipoprotein Fractionation, Ion Mobility
884
Early Onset Obesity Evaluation2
Detects mutations in BBS1, BBS2, and BBS10.
19584
15102(X)
Includes thyroglobulin and thyroglobulin antibody.
Thyroglobulin Panel with HAMA Treatment
Includes thyroglobulin, pre and post HAMA precipitation, and
thyroglobulin antibody.
Thyroid Cascading Reflex
Initial TSH results will determine further reflex orders of Free T4, TPO
antibodies, and Free T3.
Resistance to Thyroid Hormone
7260(X)
Thyroid Peroxidase and Thyroglobulin Antibodies
8658(X)
Alpha Subunit1
5081
Thyroid Peroxidase Antibody (Anti-TPO)
16053(X)
Resistance to Thyroid Hormone (RTH) Mutation Analysis1
899
TSH
36598
T3, Free, Tracer Dialysis
36577
TSH Antibody1
Detects mutations in LEPR and MC4R.
859
T3, Total
90896
TSH, Pregnancy
883
Early Onset Obesity (LEPR) DNA Sequencing Test2
36574
T3 (Triiodothyronine) Antibody
19537
TSH with HAMA Treatment
640
Early Onset Obesity (MC4R) DNA Sequencing Test2
36576
T4 (Thyroxine) Antibody1
36127(X)
TSH with Reflex to Free T4
TSI (Thyroid Stimulating Immunoglobulin)
Ferritin
T4, Free, Direct Dialysis
30551
457
35167
467(X)
Folate, RBC
866
T4, Free (Non-dialysis)
466
Folate, Serum
17733
T4, Total (Thyroxine)
5738
TBII (Thyrotropin-Binding Inhibitory Immunoglobulin)
Detects mutations in MC4R.
QuestDiagnostics.com
Quest, Quest Diagnostics, AssessR, Cardio IQ, QuestAssureD, XSense, any associated
logos, and all associated Quest Diagnostics registered or unregistered trademarks are
the property of Quest Diagnostics. All third party marks - ® and ™ - are the property of
their respective owners. © 2014 Quest Diagnostics Incorporated. All rights reserved.
TL3670 02/2014